Type 2 Diabetes: Once-Weekly Retatrutide

We are investigating how well once-weekly Retatrutide works for people with type 2 diabetes and its effects on blood sugar levels. This study aims to understand the risk of hypoglycemia in participants.

6-12 monthsSafety phase (I)DiabetologyEndocrinology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medical University Of Graz
Division of Endocrinology and Diabetology
Graz, Austria
Sponsor: Eli Lilly & Co.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.